Systematic erythalamus (SLE) is a self-immunological disease that not only affects skin, joints, but also exhausts important organs such as the heart and increases the risk of cardiovascular disease. Understanding the risk assessment and prevention methods of SLE cardiovascular diseases is important for patients.
The reasons for the increased risk of cardiovascular disease in SLE patients are complex. First, chronic inflammation caused by the disease itself can damage the vascular cell and contribute to the sclerosis of the artery. Second, patients often require long-term treatment with drugs such as sugar cortex hormones, which can lead to increased blood pressure, blood resin abnormalities and increased blood sugar, which in turn increases cardiovascular risk. In addition, the presence of self-antibodies in SLE patients and the disorders of the immune system interfere with the normal functioning of the cardiovascular system.
For SLE patients, the risk assessment of cardiovascular diseases is essential. Doctors usually make judgements by combining a wide range of factors, including traditional cardiovascular risk factors such as age, sex, blood pressure, blood resin, blood sugar levels, etc. At the same time, factors associated with the disease, such as the extent of SLE ‘ s disease activity, the length of its course and the existence of kidney damage, are taken into account. Special examinations, such as the assessment of the inner thickness of the carotid membrane of the cervical artery, the examination of the heart structure and function of the heart, contribute to early detection of cardiovascular disease. In addition, indicators to detect inflammation in blood, such as C-reacting protein, blood sank, etc., can also reflect the correlation between the disease ‘ s inflammation state and cardiovascular risk.
Active control of SLE disease activities is key in combating it. Patients are required to follow strictly the usual medical prescriptions and are regularly reviewed so that doctors can adjust their treatment programmes in a timely manner. For medicines that may affect cardiovascular health, such as sugar cortex hormones, the doctor weighs the advantages and disadvantages, uses the lowest effective dose possible and closely monitors adverse reactions. In terms of lifestyle, patients should follow the principles of healthy diet, reduce the intake of salt, saturated fat and cholesterol, and increase the intake of vegetables and fruits, whole grains and quality proteins. Moderate physical exercise, such as walking, yoga, swimming, etc., helps to control weight and improve cardiovascular functions, but the strength and time of the exercise should be reasonable in the light of their physical condition and avoid overwork. Prohibition of alcohol is also essential to reduce cardiovascular risk, and smoking can further damage the inside of the veins and increase cardiovascular damage, while excessive drinking may affect indicators such as blood pressure, blood resin, etc. At the same time, patients are also required to attend to and control blood pressure, blood resin and blood sugar levels and, in case of abnormalities, to receive timely medical treatment and, if necessary, medical treatment.
In short, the risk of cardiovascular disease for SLE patients cannot be ignored. Through scientific risk assessments, patients are able to learn about their cardiovascular health, leading to effective prevention and treatment measures, including active treatment of SLE, lifestyle adjustment and control of associated risk factors. This helps to reduce the risk of cardiovascular disease, improve the quality of life and allow patients to live with disease and enjoy a healthy life.
